Omid Seidizadeh: Pleased to Announce the Establishment of EAHAD Working Group on VWD
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, reposted from EAHAD on LinkedIn:
”We are pleased to announce the establishment of the European Association for Haemophilia and Allied Disorders (EAHAD) Working Group on von Willebrand Disease (VWD).
My sincere thanks go to the EAHAD Executive Committee for supporting my proposal to establish this group, to Isidora Laur Vukovic and Angelos Athanasopoulos for their invaluable help, and to all the members who have joined us in this important initiative.
We look forward to advancing research, clinical practice, and collaboration in the field of VWD across Europe and beyond.”
Quoting European Association for Haemophilia and Allied Disorders (EAHAD)‘s post:
”Introducing our new Working Group on Von Willebrand Disease (VWD)
This week, we held the first meeting of the VWD Working Group with experts from across Europe marking the start of an exciting collaborative journey with the aim of building a strong European network to advance knowledge, enhance care, and shape the future of VWD management.
Discover more.”
Stay updated with Hemostasis Today.
-
Nov 5, 2025, 06:51Petros Gatsios Explains Why Europe Must Become Self-Sufficient in Maintaining Its Plasma Supply
-
Nov 5, 2025, 04:08Omid Seidizadeh: Pleased to Announce the Establishment of EAHAD Working Group on VWD
-
Nov 5, 2025, 03:54Marilena Vrana: ''Plasma Powers Possibility'' Continues to Resonate Far Beyond an Awareness Week
-
Nov 5, 2025, 03:30Dirk Sibbing on The Importance of ISAR-REACT 5 trial and 2020 ESC Guidelines for ACS
-
Nov 5, 2025, 03:14Abrham Mulugeta Shares Insights on Tranexamic Acid: Exploring the WHO WOMAN Trial
-
Nov 4, 2025, 08:57Toluwalase Awoyemi: Digital Health Meets Maternal Heart Care
-
Nov 4, 2025, 08:53Rebecca Ahrens Nicklas Shares FDA Interactions on Interventional Genetics with The Rare Disease Community
-
Nov 4, 2025, 06:37AI Meets Cardiology Guidelines․ Our JACC Study Is Live
-
Nov 3, 2025, 09:13Claudio Carrubba on How Timing Truly Matters in Trauma Embolization
-
Nov 3, 2025, 08:57Multiplex Apolipoprotein Panel Boosts Cardiovascular Risk Prediction and Precision Therapy
-
Nov 4, 2025, 09:10OCCUPI Trial Analysis Highlights Benefits of OCT Guidance in ACS Patients
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Nov 4, 2025, 09:17HaemophiliaIRL Series Begins․ Advances in von Willebrand Disease Treatment
-
Nov 4, 2025, 09:14Exploring Molecular Pathways of Aging in Hematopoiesis․ FEBS Workshop 2025
-
Nov 4, 2025, 08:28Fritz Roth Thanks Supporters of Science Magazine Study Linking Genes to High Cholesterol and Heart Attack Risk
-
Nov 4, 2025, 08:22Colleen Silk on Novo Nordisk Taking the 2025 Prix Galien US Award
-
Nov 4, 2025, 08:14Cristina Anton: Excited to Be Part of Women in Hematology!